Low Oxygen = Treatment Failure | What Oncologists Miss

#outsmartcancer #precisiononcology #oxygentherapy #drdinoprato
#targetedcancercare

What if cancer treatments fail — not because the drugs are wrong — but because the environment is broken?

In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains how tumor hypoxia — low oxygen inside solid tumors — blocks chemotherapy, immunotherapy, and even gene-targeted drugs from working properly. When oxygen is low, cancer flips on hypoxia-inducing factor alpha (HIF-1α), shifts into sugar fermentation (the Warburg effect), suppresses immune cells, and builds resistance.

Dr. Prato breaks down how oxygen-based therapies, including hyperbaric oxygen and medical ozone therapy, can act as precision adjuvants — not replacements — to restore oxygen balance, mitochondrial function, and immune responsiveness. Hyperbaric oxygen drives oxygen deep into hypoxic tissue, while ozone therapy creates a controlled oxidative “spark” that activates mitochondria, antioxidant systems, and immune signaling.

The key is precision. Using RNA transcriptomics, immune profiling, and spatial biology, doctors can measure hypoxia markers like HIF-1α, VEGF, and glycolytic genes to determine when oxygen priming is appropriate. When used correctly — before targeted chemotherapy, immunotherapy, or radiation — oxygen therapy can help treatments penetrate tumors, reduce side effects, and improve response.

???? What You’ll Learn in This Episode:
• Why cancer thrives in low-oxygen, high-sugar environments
• How hypoxia-inducing factor alpha drives resistance and immune suppression
• The difference between hyperbaric oxygen and ozone therapy
• How controlled oxidative stress activates mitochondria and immunity
• Why oxygen therapy is a primer — not a standalone cancer treatment
• How precision testing determines who benefits from oxygen-based therapy
• How oxygen priming improves chemo, radiation & immunotherapy response
• Why balance, timing, and medical supervision are essential

???? Envita Medical Centers – Scottsdale, AZ
???? Learn more: https://www.envita.com/?utm_source=DrDinoPodcast
???? Speak with a care coordinator: 866-830-4576

“Cancer suffocates the body. Precision care helps it breathe again.”

???? About Dr. Dino Prato and Envita Medical Centers
My life's work at Envita Medical Centers has been a mission to help patients find hope when they've run out of options. As a pioneer in precision personalized medicine, I founded Envita Medical Centers to offer next-level care. We use state-of-the-art testing and treatments that are not only data-driven but also precisely targeted to each individual.

By the grace of God, we've been able to help many families. Our approach isn't about treating a disease; it's about treating a unique person and providing a custom blueprint for healing. We believe every life is precious and unrepeatable, and we approach each patient with the love and dignity they deserve. The message we give them is one of life and hope.

???? Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem.

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493